Table 2 Comparisons of variables between patients with gout and patients with asymptomatic hyperuricemia
Variable | Gout (n = 653) | Asymptomatic hyperuricemia (n = 63) | p |
|---|---|---|---|
Demographic and clinical characteristics | |||
Male, n (%) | 553 (84.7) | 51 (81.0) | 0.436 a |
Age (years) | 48.3 ± 15.8 | 43.3 ± 17.9 | 0.018*b |
≤30 | 84 | 20 | |
31–50 | 290 | 22 | |
51–70 | 214 | 15 | |
71–90 | 65 | 6 | |
BMI (kg/ m2) | 24.2 (21.8–26.9) | 23.9 (21.7–27.2) | 0.582 c |
Age of hyperuricemia onset (years) | 40.7 ± 15.6 | 36.2 ± 17.8 | 0.565 b |
Hyperuricemia duration (years) | 6.0 (2.0–12.0) | 6.0 (2.0–11.0) | 0.935 c |
Hypertension, n (%) | 170 (26.0) | 12 (19.0) | 0.224 a |
Coronary heart disease, n (%) | 67 (10.3) | 5 (7.9) | 0.558 a |
Laboratory testing | |||
AST (U/L) | 22.0 (17.6–27.6) | 22.0 (17.2–25.8) | 0.958 c |
ALT(U/L) | 24.0 (16.0–38.6) | 23.8 (15.9–32.8) | 0.343 c |
TP(g/L) | 73.9 (70.0–77.7) | 74.6 (71.9–77.8) | 0.519 c |
ALB(g/L) | 44.3 (40.9–46.8) | 45.5 (41.6–48.8) | 0.095 c |
TB (μmol/L) | 13.1 (9.6–17.3) | 16.2 (10.9–20.0) | 0.078 c |
BUN (mmol/L) | 4.85 (4.0–6.2) | 4.9 (4.1–6.5) | 0.678 c |
Serum creatine (mmol/L) | 90.0 (78.0–106.2) | 83.9 (72.1–103.4) | 0.036*c |
sUA (μmol/L) | 513.0 (376.5–602.0) | 515.0 (438.0–592.0) | 0.471 c |
Glucose (mmol/L) | 5.23 (4.80–5.96) | 5.23 (4.70–6.23) | 0.959 c |
TC (mmol/L) | 5.1 ± 1.1 | 4.7 ± 1.0 | 0.020*b |
TG (mmol/L) | 1.61 (1.12–2.45) | 1.80 (1.06–2.67) | 0.959 c |
HDL-C (mmol/L) | 1.14 (0.97–1.39) | 1.14 (0.99–1.36) | 0.975 c |
LDL-C (mmol/L) | 3.27 (2.62–3.87) | 3.05 (2.39–3.70) | 0.126 b |
ESR (mm/h) | 31.0 (15.0–54.0) | 21.0 (14.3–30.5) | 0.066 c |
CRP (mg/L) | 6.53 (4.71–25.1) | 4.95 (4.50–10.3) | 0.040*c |